WO1999056727A3 - Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems - Google Patents

Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems Download PDF

Info

Publication number
WO1999056727A3
WO1999056727A3 PCT/IE1999/000031 IE9900031W WO9956727A3 WO 1999056727 A3 WO1999056727 A3 WO 1999056727A3 IE 9900031 W IE9900031 W IE 9900031W WO 9956727 A3 WO9956727 A3 WO 9956727A3
Authority
WO
WIPO (PCT)
Prior art keywords
preconcentrate
solvent
emulsion
drug delivery
delivery systems
Prior art date
Application number
PCT/IE1999/000031
Other languages
French (fr)
Other versions
WO1999056727A2 (en
Inventor
Zebunnissa Ramtoola
Nuala Marie Clarke
Original Assignee
Elan Corp Plc
Zebunnissa Ramtoola
Nuala Marie Clarke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp Plc, Zebunnissa Ramtoola, Nuala Marie Clarke filed Critical Elan Corp Plc
Priority to JP2000546754A priority Critical patent/JP2002513750A/en
Priority to EP99921098A priority patent/EP1075252A2/en
Priority to AU38439/99A priority patent/AU3843999A/en
Priority to CA002331640A priority patent/CA2331640A1/en
Publication of WO1999056727A2 publication Critical patent/WO1999056727A2/en
Publication of WO1999056727A3 publication Critical patent/WO1999056727A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Self-emulsifying microemulsion or emulsion preconcentrate pharmaceutical compositions capable of forming an oil-in-water microemulsion or emulsion upon dilution with an aqueous solution are disclosed. The preconcentrate contains a therapeutically effective amount of a poorly water soluble therapeutic agent; a pharmaceutically effective amount of a low HLB oil component; and a surfactant system consisting essentially of at least one surfactant having an HLB of from about 10 to 20 and is substantially free or contains only minor amounts of a hydrophilic solvent system. Microemulsions or emulsions formed by diluting the self-emulsifying preconcentrate with an aqueous solution are also provided.
PCT/IE1999/000031 1998-05-07 1999-05-07 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems WO1999056727A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000546754A JP2002513750A (en) 1998-05-07 1999-05-07 Solvent / co-solvent free microemulsion and emulsion pre-concentrate drug delivery system
EP99921098A EP1075252A2 (en) 1998-05-07 1999-05-07 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
AU38439/99A AU3843999A (en) 1998-05-07 1999-05-07 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
CA002331640A CA2331640A1 (en) 1998-05-07 1999-05-07 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8451898P 1998-05-07 1998-05-07
US60/084,518 1998-05-07

Publications (2)

Publication Number Publication Date
WO1999056727A2 WO1999056727A2 (en) 1999-11-11
WO1999056727A3 true WO1999056727A3 (en) 2000-03-02

Family

ID=22185451

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE1999/000031 WO1999056727A2 (en) 1998-05-07 1999-05-07 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems

Country Status (5)

Country Link
EP (1) EP1075252A2 (en)
JP (1) JP2002513750A (en)
AU (1) AU3843999A (en)
CA (1) CA2331640A1 (en)
WO (1) WO1999056727A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709669B2 (en) 2000-02-16 2010-05-04 The Brigham And Women's Hospital, Inc. Aspirin-triggered lipid mediators
US7741368B2 (en) 2001-12-18 2010-06-22 The Brigham And Women's Hospital, Inc. Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
US9364454B2 (en) 2005-10-03 2016-06-14 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
AU7638200A (en) * 1999-10-20 2001-04-30 Vesifact Ag Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions
SE0000774D0 (en) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (en) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
MY120392A (en) * 2000-06-08 2005-10-31 Hovid Berhad A novel drug delivery system : formulation for fat-soluble drugs
JP4593074B2 (en) * 2000-10-11 2010-12-08 セフアロン・インコーポレーテツド Modafinil compound-containing composition
FR2818905A1 (en) * 2000-12-28 2002-07-05 Cll Pharma MICELLAR COLLOIDAL PHARMACEUTICAL COMPOSITIONS COMPRISING A LIPOPHILIC ACTIVE INGREDIENT
EP1377273B1 (en) * 2001-02-11 2009-03-18 Aquanova Ag Method for producing an isoflavone concentrate
IL157130A0 (en) * 2001-02-14 2004-02-08 Gw Pharma Ltd A cannabis based pharmaceutical formulation
DE50101395D1 (en) * 2001-04-12 2004-03-04 Vesifact Ag Baar Pharmaceutical formulations containing anti-inflammatory agents and their use
SE0102993D0 (en) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
KR100441167B1 (en) * 2001-12-27 2004-07-21 씨제이 주식회사 Composition of microemulsion preconcentrate
US7582785B2 (en) 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
CA2493878C (en) 2002-07-30 2013-07-23 Wyeth Parenteral formulations containing a rapamycin hydroxyester
EP1537067B1 (en) 2002-08-12 2009-11-18 Brigham And Women's Hospital Resolvins: biotemplates for therapeutic interventions
US20040146551A1 (en) 2002-11-01 2004-07-29 Biodelivery Sciences International, Inc. Geodate delivery vehicles
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
FR2853527B1 (en) * 2003-04-11 2006-06-23 Oreal COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION CONTAINING AN AMPHIPHILIC POLYMER, AND ITS PARTICULARLY COSMETIC USES
US7879345B2 (en) 2003-04-11 2011-02-01 L'oreal Composition containing an amphiphilic polymer, uses thereof
JP2007528388A (en) * 2004-03-10 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Composition comprising molecularly dispersed drospirenone
ES2425937T3 (en) * 2004-03-24 2013-10-18 Takeda Pharmaceutical Company Limited Emulsion stabilizer
US20050232974A1 (en) * 2004-04-19 2005-10-20 Gore Makarand P System and a method for pharmaceutical dosage preparation using jettable microemulsions
SG155189A1 (en) * 2004-08-06 2009-09-30 Transform Pharmaceuticals Inc Novel fenofibrate formulations and related methods of treatment
CN100361656C (en) 2004-08-27 2008-01-16 石药集团中奇制药技术（石家庄）有限公司 Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application
GT200500310A (en) 2004-11-19 2006-06-19 ORGANIC COMPOUNDS
WO2008051186A2 (en) * 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
US20140287004A1 (en) * 2005-11-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
WO2014160989A2 (en) 2013-03-28 2014-10-02 The Trustees Of Columbia University In The City Of New York Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
WO2007059431A1 (en) * 2005-11-14 2007-05-24 The Trustees Of Columbia University In The City Of New York Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
EP1957053A4 (en) * 2005-11-17 2012-03-28 Bioavailability Inc Biocompatible latent emulsifiers
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
PT2068825E (en) * 2006-10-04 2011-02-11 M & P Patent Ag Controlled release delivery system for nasal application of neurotransmitters
PL2192893T3 (en) * 2007-08-21 2015-12-31 Basilea Pharmaceutica Ag Antifungal composition
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
FR2925855B1 (en) 2007-12-26 2010-11-05 Virbac Sa FLORFENICOL SELF-CONTAINING LIQUID COMPOSITION FOR INCORPORATING BEVERAGE WATER IN ANIMAL BREEDING ANIMALS.
EP2405902B1 (en) 2009-03-09 2021-07-21 Basf As Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
EP2433630A4 (en) * 2009-05-22 2014-01-08 Mochida Pharm Co Ltd Self-emulsifying composition of 3 fatty acid
JP2011006380A (en) * 2009-05-22 2011-01-13 Mochida Pharmaceut Co Ltd EMULSIFIED COMPOSITION OF ω3 FATTY ACID
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
KR20200013123A (en) * 2009-10-23 2020-02-05 바스프 에이에스 Coated capsules and tablets of a fatty acid oil mixture
EP2366408B1 (en) 2010-03-01 2012-07-18 Laboratorios SALVAT, S.A. Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
KR101752944B1 (en) 2010-05-03 2017-07-03 테이코쿠 팔마 유에스에이, 인코포레이티드 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
AR082930A1 (en) * 2010-09-08 2013-01-16 Pronova Biopharma Norge As COMPOSITIONS THAT INCLUDE AN OILY MIXTURE OF FATTY ACIDS, A TENSIOACTIVE AND A STATIN
EP2613767A4 (en) * 2010-09-08 2014-03-19 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
EP2613766A4 (en) * 2010-09-08 2014-04-09 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
JO3337B1 (en) * 2010-12-13 2019-03-13 Debiopharm Sa Pharmaceutical Compositions Comprising Alisporivir
JO3685B1 (en) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc Non-aqueous taxane nanodispersion formulations and methods of using the same
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
US10736842B2 (en) 2014-06-25 2020-08-11 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
US11260018B2 (en) 2015-09-17 2022-03-01 Jrx Biotechnology, Inc. Approaches for improving skin hydration and moisturization
US20230158018A1 (en) * 2018-09-13 2023-05-25 Ftf Pharma Private Limited Non-aqueous chemotherapeutic suspensions for oral dosage
US20200215027A1 (en) * 2018-12-28 2020-07-09 Robert K. Prud'homme Dihydromyricetin nanoemulsion formulations and methods for forming them
US11465107B2 (en) * 2019-01-31 2022-10-11 Hong Ngoc Thi Dang Process for producing a nano omega-3 microemulsion system
CZ309587B6 (en) * 2021-01-22 2023-05-03 Oncora S.R.O. Microemulsion preconcentrate containing cladribine and preparing it

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2372635A1 (en) * 1976-12-03 1978-06-30 Scherer Ltd R P Pharmaceutical compsn. contg. self-emulsifying oil e.g. silicone - for admin. as capsules, giving rapid gastrointestinal resorption
WO1994005298A1 (en) * 1992-08-28 1994-03-17 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
WO1995008983A1 (en) * 1993-09-30 1995-04-06 Gattefosse S.A. Oral delivery composition forming a microemulsion
EP0650721A1 (en) * 1993-07-01 1995-05-03 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin soft capsule
WO1995012384A1 (en) * 1993-11-02 1995-05-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsible formulation forming an oil-in-water emulsion
WO1995025504A1 (en) * 1994-03-18 1995-09-28 Pharmavene, Inc. Emulsified drug delivery systems
WO1996013273A1 (en) * 1994-10-26 1996-05-09 Novartis Ag Pharmaceutical compositions
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
WO1997036610A1 (en) * 1996-07-26 1997-10-09 Chong Kun Dang Corp. Cyclosporin-containing pharmaceutical composition
FR2753376A1 (en) * 1996-09-18 1998-03-20 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING AMISULPRIDE AND THERAPEUTIC APPLICATIONS THEREOF
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
WO1999029300A1 (en) * 1997-12-10 1999-06-17 Rtp Pharma Inc. Self-emulsifying fenofibrate formulations

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2372635A1 (en) * 1976-12-03 1978-06-30 Scherer Ltd R P Pharmaceutical compsn. contg. self-emulsifying oil e.g. silicone - for admin. as capsules, giving rapid gastrointestinal resorption
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
WO1994005298A1 (en) * 1992-08-28 1994-03-17 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
EP0650721A1 (en) * 1993-07-01 1995-05-03 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin soft capsule
WO1995008983A1 (en) * 1993-09-30 1995-04-06 Gattefosse S.A. Oral delivery composition forming a microemulsion
WO1995012384A1 (en) * 1993-11-02 1995-05-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsible formulation forming an oil-in-water emulsion
WO1995025504A1 (en) * 1994-03-18 1995-09-28 Pharmavene, Inc. Emulsified drug delivery systems
WO1996013273A1 (en) * 1994-10-26 1996-05-09 Novartis Ag Pharmaceutical compositions
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
WO1997036610A1 (en) * 1996-07-26 1997-10-09 Chong Kun Dang Corp. Cyclosporin-containing pharmaceutical composition
FR2753376A1 (en) * 1996-09-18 1998-03-20 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING AMISULPRIDE AND THERAPEUTIC APPLICATIONS THEREOF
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
WO1999029300A1 (en) * 1997-12-10 1999-06-17 Rtp Pharma Inc. Self-emulsifying fenofibrate formulations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CRAIG D Q M ET AL: "A COMPARISON OF THE SELF-EMULSIFYING PROPERTIES OF POLYGLYCOLYSED GLYCERIDE OILS", PHARMACEUTICAL SCIENCES,GB,LONDON, vol. 1, no. 12, pages 559-561, XP002053051, ISSN: 1356-6881 *
SHAH N H ET AL: "SELF-EMULSIFYING DRUG DELIVERY SYSTEMS (SEDDS) WITH POLYGLYCOLYZED GLYCERIDES FOR IMPROVING IN VITRO DISSOLUTION AND ORAL ABSORPTION OF LIPOPHILIC DRUGS", INTERNATIONAL JOURNAL OF PHARMACEUTICS,NL,AMSTERDAM, vol. 106, no. 1, pages 15-23, XP000561369, ISSN: 0378-5173 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709669B2 (en) 2000-02-16 2010-05-04 The Brigham And Women's Hospital, Inc. Aspirin-triggered lipid mediators
US7741368B2 (en) 2001-12-18 2010-06-22 The Brigham And Women's Hospital, Inc. Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
US7872152B2 (en) 2002-08-12 2011-01-18 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
US8933270B2 (en) 2002-08-12 2015-01-13 The Brigham And Women's Hospital, Inc. Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
US9364454B2 (en) 2005-10-03 2016-06-14 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers

Also Published As

Publication number Publication date
WO1999056727A2 (en) 1999-11-11
JP2002513750A (en) 2002-05-14
CA2331640A1 (en) 1999-11-11
AU3843999A (en) 1999-11-23
EP1075252A2 (en) 2001-02-14

Similar Documents

Publication Publication Date Title
WO1999056727A3 (en) Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
CA2313024A1 (en) Pharmaceutical compositions containing an omega-3 fatty acid oil
WO1996040057A3 (en) Reverse fluorocarbon emulsion compositions for drug delivery
Kawakami et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs: II. In vivo study
MacGregor et al. Influence of lipolysis on drug absorption from the gastro-intestinal tract
US4719239A (en) Pharmaceutical multicomponent systems and method of preparing same
Nicolaos et al. Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion
Marti-Mestres et al. Emulsions in health care applications—an overview
US5906831A (en) Controlled release composition forming a reversed micellar (L2) structure or a normal micellar (L1) structure
JP5764792B2 (en) Novel pharmaceutical composition comprising a macrolide immunosuppressant
CA2142103A1 (en) Submicron emulsions as ocular drug delivery vehicles
US5389373A (en) Preparation of oil-in-water emulsions of drugs
CA2194226A1 (en) Stable Oil-In-Water Emulsions Incorporating a Taxine (Taxol) and Method of Making Same
CA2458448A1 (en) Spontaneous emulsions containing cyclosporine
Trotta et al. Investigation of the phase behaviour of systems containing lecithin and 2-acyl lysolecithin derivatives
ATE183079T1 (en) STABLE REVERSAL AND MULTIPLE FLUOROCARBON EMULSIONS
KR900004323A (en) Emulsifying composition
TNSN94099A1 (en) NEW EMULSION COMPOSITIONS
KR970064620A (en) Cyclosporin-containing external-use pharmaceutical composition
ATE152613T1 (en) COMPOSITION WHICH FORMES A MICROEMULSION UPON PERORAL ADMINISTRATION
KR930001929A (en) Ophthalmic Composition
WO1998005300A2 (en) Delivery system for pharmaceutical agents encapsulated with oils
WO1997005882A1 (en) O/w emulsion composition for eye drops
ATE79262T1 (en) MEDICINAL EMULSION.
US6770292B2 (en) Pharmaceutical compositions for oral administration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999921098

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2331640

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 38439/99

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1999921098

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999921098

Country of ref document: EP